Sinopharm Medicine Holding Restructures Ningxia Pharmaceutical Commerce Group
This article was originally published in PharmAsia News
Executive Summary
Sinopharm Medicine Holding, a subsidiary of state-owned Sinopharm, has completed the merger of Ningxia Pharmaceutical Commerce Group. Sinopharm's fourth acquisition this year, the latest purchase will become part of the group's business platform. The restructuring is now in the final stages of assets checking, capital injection and name change. Sinopharm Medicine will hold 100 percent and more than 70 percent of Ningxia Pharmaceutical's retail and trading business, respectively. Financial details of the transaction are not disclosed. (Click here for more - Chinese Language)